A Comparison Study of Olmesartan and Valsartan Effects on Myocardial Metabolism in Patients With Dilated Cardiomyopathy: the OVOID Trial
Journal of the American Heart Association · 2025
DOI: 10.1161/jaha.125.041406 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Sangyong Jo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine, Regional Cardiocerebrovascular Center Dong-A University Hospital Busan Republic of Korea. Hauptthemen laut MEDLINE: Valsartan, Cardiomyopathy, Dilated, Imidazoles, Tetrazoles. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Myocardial metabolism plays an important role in maintaining cardiac function. Patients with dilated cardiomyopathy exhibit alterations in myocardial metabolism characterized by increased myocardial glucose metabolism. This study aimed to evaluate effects on myocardial metabolism of the angiotensin II receptor blockers olmesartan and valsartan in patients with dilated cardiomyopathy. We hypothesized that olmesartan, owing to its stronger and longer‐lasting angiotensin II receptor blockade, would lead to a greater reduction in myocardial glucose metabolism compared with valsartan.
Methods
OVOID (A Comparison Study of Olmesartan and Valsartan Effects on Myocardial Metabolism in Patients With Dilated Cardiomyopathy) was a multicenter, randomized controlled trial involving 44 patients with New York Heart Association classes II through IV dilated cardiomyopathy. Participants were randomized 1:1 to receive olmesartan (20 mg once daily) or valsartan (160 mg twice daily) for 6 months, in addition to standard care. The primary outcome was myocardial glucose metabolism measured by standardized uptake value ratio at 6 months after treatment. To measure standardized uptake value ratio, 18 F‐fluoro‐2‐deoxyglucose cardiac positron emission tomography was performed at baseline and 6 months after receiving the study agent.
Results
Baseline clinical characteristics and standardized uptake value ratio were not significantly different between the 2 groups. The average left ventricular ejection fraction was 25.1%±7.8% at baseline, with significant improvement in both groups after 6 months, though with no difference between them. At 6 months, the standardized uptake value ratio value was significantly lower in the olmesartan group than that in the valsartan (3.76±2.00 versus 5.76±3.10; P =0.01).
Conclusions
Six months of olmesartan therapy significantly decreased myocardial glucose metabolism in dilated cardiomyopathy patients compared with valsartan therapy for 6 months. Registration URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04174456.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Department of Internal Medicine, Regional Cardiocerebrovascular Center Dong-A University Hospital Busan Republic of Korea.
- Dong-A University College of Medicine Busan Republic of Korea.
- Gimhaebokum Hospital Gimhae Republic of Korea.
- Ulsan Medical Center Ulsan Republic of Korea.
- Dong-eui Hospital Busan Republic of Korea.
- Busan St.Mary's Hospital Busan Republic of Korea.
ORCID-Profile: Sangyong Jo, Kyungil Park, Su Hong Kim
Zitieren
APA
Jo, S., Park, K., Choi, J. H., Sohn, C. B., Kim, J., Kwon, Y. S., Kim, S. H., & Park, T. H. (2025). A Comparison Study of Olmesartan and Valsartan Effects on Myocardial Metabolism in Patients With Dilated Cardiomyopathy: the OVOID Trial. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.041406
Vancouver
Jo S, Park K, Choi JH, Sohn CB, Kim J, Kwon YS, et al. A Comparison Study of Olmesartan and Valsartan Effects on Myocardial Metabolism in Patients With Dilated Cardiomyopathy: the OVOID Trial. Journal of the American Heart Association. 2025. doi:10.1161/jaha.125.041406
BibTeX
@article{Jo2025,
author = {Jo, Sangyong and Park, Kyungil and Choi, Jae Hyuk and Sohn, Chang-Bae and Kim, Jeonghwan and Kwon, Yong-Seop and Kim, Su Hong and Park, Tae-Ho},
title = {A Comparison Study of Olmesartan and Valsartan Effects on Myocardial Metabolism in Patients With Dilated Cardiomyopathy: the OVOID Trial},
journal = {Journal of the American Heart Association},
year = {2025},
doi = {10.1161/jaha.125.041406}
}
EUVIMED